Named on 2 rounds in the feed.
Rounds from 2026-03-05 to 2026-06-22
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Bionyra Pharma Bionyra Pharma is a clinical-stage biopharmaceutical company developing next-generation biologics for severe immune-mediated inflammatory diseases. | Series A Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $165M | 2026-06-22 | [ PART ] |
Cognito Therapeutics Cognitotx sells a non-invasive neuroprotective therapy platform designed to evoke brain wave activity to benefit Alzheimer's patients. | Series C Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $105M | 2026-03-05 | [ PART ] |